Strategies to decrease costs of prescribing selective serotonin reuptake inhibitors at a VA Medical Center

Steven Dobscha, Thomas A. Anderson, William F. Hoffman, Lisa M. Winterbottom, Erick Turner, Leann S. Snodgrass, Peter Hauser

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Objective: The authors examined the efficacy of a multifaceted intervention designed to contain the cost of prescribing selective serotonin reuptake inhibitors (SSRIs) to inpatients and outpatients served by a Veterans Affairs (VA) medical center. Methods: Elements of the intervention included identification of a preferred agent, tablet splitting, education and feedback for prescribers, and an electronic record and ordering system to facilitate changes in prescriber behaviors. VA databases were searched for information on use and costs of antidepressants. Results: Over 35 months the number of patients treated with SSRIs and the amount spent on SSRIs increased. However, the mean monthly cost per patient decreased from $57.12 to $42.19. The projected cost savings over the 35 months was approximately $700,000; one-fourth of the savings was due to tablet splitting and three-fourths to changes in the proportions of the various SSRIs prescribed. A survey of the top 75 antidepressant prescribers showed that after the educational interventions, 91 percent were aware that citalopram was the medical center's preferred antidepressant, and 59 percent identified it as their own preferred first-line treatment. Discussion and conclusions: The results suggest that multifaceted interventions can influence antidepressant costs through provider education and changes in pharmacy and computerized information processes, resulting in substantial cost savings for institutions.

Original languageEnglish (US)
Pages (from-to)195-200
Number of pages6
JournalPsychiatric Services
Volume54
Issue number2
DOIs
StatePublished - Feb 1 2003

Fingerprint

Serotonin Uptake Inhibitors
Veterans
Antidepressive Agents
Costs and Cost Analysis
Cost Savings
costs
Tablets
savings
Education
Citalopram
Inpatients
information process
Outpatients
Databases
education
electronics
Therapeutics

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Public Health, Environmental and Occupational Health
  • Health(social science)
  • Health Professions(all)

Cite this

Strategies to decrease costs of prescribing selective serotonin reuptake inhibitors at a VA Medical Center. / Dobscha, Steven; Anderson, Thomas A.; Hoffman, William F.; Winterbottom, Lisa M.; Turner, Erick; Snodgrass, Leann S.; Hauser, Peter.

In: Psychiatric Services, Vol. 54, No. 2, 01.02.2003, p. 195-200.

Research output: Contribution to journalArticle

Dobscha, Steven ; Anderson, Thomas A. ; Hoffman, William F. ; Winterbottom, Lisa M. ; Turner, Erick ; Snodgrass, Leann S. ; Hauser, Peter. / Strategies to decrease costs of prescribing selective serotonin reuptake inhibitors at a VA Medical Center. In: Psychiatric Services. 2003 ; Vol. 54, No. 2. pp. 195-200.
@article{08da08ce59424013b42e15fa73c6f364,
title = "Strategies to decrease costs of prescribing selective serotonin reuptake inhibitors at a VA Medical Center",
abstract = "Objective: The authors examined the efficacy of a multifaceted intervention designed to contain the cost of prescribing selective serotonin reuptake inhibitors (SSRIs) to inpatients and outpatients served by a Veterans Affairs (VA) medical center. Methods: Elements of the intervention included identification of a preferred agent, tablet splitting, education and feedback for prescribers, and an electronic record and ordering system to facilitate changes in prescriber behaviors. VA databases were searched for information on use and costs of antidepressants. Results: Over 35 months the number of patients treated with SSRIs and the amount spent on SSRIs increased. However, the mean monthly cost per patient decreased from $57.12 to $42.19. The projected cost savings over the 35 months was approximately $700,000; one-fourth of the savings was due to tablet splitting and three-fourths to changes in the proportions of the various SSRIs prescribed. A survey of the top 75 antidepressant prescribers showed that after the educational interventions, 91 percent were aware that citalopram was the medical center's preferred antidepressant, and 59 percent identified it as their own preferred first-line treatment. Discussion and conclusions: The results suggest that multifaceted interventions can influence antidepressant costs through provider education and changes in pharmacy and computerized information processes, resulting in substantial cost savings for institutions.",
author = "Steven Dobscha and Anderson, {Thomas A.} and Hoffman, {William F.} and Winterbottom, {Lisa M.} and Erick Turner and Snodgrass, {Leann S.} and Peter Hauser",
year = "2003",
month = "2",
day = "1",
doi = "10.1176/appi.ps.54.2.195",
language = "English (US)",
volume = "54",
pages = "195--200",
journal = "Psychiatric Services",
issn = "1075-2730",
publisher = "American Psychiatric Association",
number = "2",

}

TY - JOUR

T1 - Strategies to decrease costs of prescribing selective serotonin reuptake inhibitors at a VA Medical Center

AU - Dobscha, Steven

AU - Anderson, Thomas A.

AU - Hoffman, William F.

AU - Winterbottom, Lisa M.

AU - Turner, Erick

AU - Snodgrass, Leann S.

AU - Hauser, Peter

PY - 2003/2/1

Y1 - 2003/2/1

N2 - Objective: The authors examined the efficacy of a multifaceted intervention designed to contain the cost of prescribing selective serotonin reuptake inhibitors (SSRIs) to inpatients and outpatients served by a Veterans Affairs (VA) medical center. Methods: Elements of the intervention included identification of a preferred agent, tablet splitting, education and feedback for prescribers, and an electronic record and ordering system to facilitate changes in prescriber behaviors. VA databases were searched for information on use and costs of antidepressants. Results: Over 35 months the number of patients treated with SSRIs and the amount spent on SSRIs increased. However, the mean monthly cost per patient decreased from $57.12 to $42.19. The projected cost savings over the 35 months was approximately $700,000; one-fourth of the savings was due to tablet splitting and three-fourths to changes in the proportions of the various SSRIs prescribed. A survey of the top 75 antidepressant prescribers showed that after the educational interventions, 91 percent were aware that citalopram was the medical center's preferred antidepressant, and 59 percent identified it as their own preferred first-line treatment. Discussion and conclusions: The results suggest that multifaceted interventions can influence antidepressant costs through provider education and changes in pharmacy and computerized information processes, resulting in substantial cost savings for institutions.

AB - Objective: The authors examined the efficacy of a multifaceted intervention designed to contain the cost of prescribing selective serotonin reuptake inhibitors (SSRIs) to inpatients and outpatients served by a Veterans Affairs (VA) medical center. Methods: Elements of the intervention included identification of a preferred agent, tablet splitting, education and feedback for prescribers, and an electronic record and ordering system to facilitate changes in prescriber behaviors. VA databases were searched for information on use and costs of antidepressants. Results: Over 35 months the number of patients treated with SSRIs and the amount spent on SSRIs increased. However, the mean monthly cost per patient decreased from $57.12 to $42.19. The projected cost savings over the 35 months was approximately $700,000; one-fourth of the savings was due to tablet splitting and three-fourths to changes in the proportions of the various SSRIs prescribed. A survey of the top 75 antidepressant prescribers showed that after the educational interventions, 91 percent were aware that citalopram was the medical center's preferred antidepressant, and 59 percent identified it as their own preferred first-line treatment. Discussion and conclusions: The results suggest that multifaceted interventions can influence antidepressant costs through provider education and changes in pharmacy and computerized information processes, resulting in substantial cost savings for institutions.

UR - http://www.scopus.com/inward/record.url?scp=0038321026&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038321026&partnerID=8YFLogxK

U2 - 10.1176/appi.ps.54.2.195

DO - 10.1176/appi.ps.54.2.195

M3 - Article

VL - 54

SP - 195

EP - 200

JO - Psychiatric Services

JF - Psychiatric Services

SN - 1075-2730

IS - 2

ER -